Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine Le Galès

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Medecine Sciences : M/S|February 1, 2018
[Evolution, determinants and regulation of drug expenditures in France]Catherine Le Galès
Medecine Sciences : M/S|April 17, 2018
[Why are new drugs so expensive?]Catherine Le Galès
Dementia (London, England)|July 9, 2016
The family accompaniment of persons with dementia seen through the lens of the capability approachCatherine Le Galès, Martine Bungener
Bulletin Du Cancer|July 15, 2003
[Assessing fatigue in the cancer patient: complementary contribution of quantitative and qualitative tools]Sophia Rosman, Catherine Le Galès
Social Science & Medicine (1982)|January 17, 2016
Capability deprivation of people with Alzheimer's disease: An empirical analysis using a national surveyJuan Tellez, Jaya Krishnakumar, Martine Bungener, et al.
Therapie|December 6, 2003
Postmarketing evaluation of drugs. Actual efficacy, population exposed and impact on public healthCatherine Le Galès, Abdelkader el Hasnaoui, Jean-Marie Goehrs
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 29, 2005
Reliability and validity of the Functional Assessment of Cancer Therapy General (FACT-G) in French cancer patientsNathalie Costet, Valérie Lapierre, Ellen Benhamou, et al.
Bulletin Du Cancer|October 11, 2021
Challenges raised by the economic evaluation of CAR-T-cell therapies. The review by the French National Authority for HealthVéronique Raimond, Emmanuelle Kaltenbach, Christophe Adam, et al.
Diagnostic Cytopathology|October 3, 2002
Cost of screening for cancerous and precancerous lesions of the cervixEstelle Méréa, Catherine Le Galès, Beatrix Cochand-Priollet, et al.
BMJ (Clinical Research Ed.)|April 5, 2003
Cross sectional study of conventional cervical smear, monolayer cytology, and human papillomavirus DNA testing for cervical cancer screeningJoël Coste, Béatrix Cochand-Priollet, Patricia de Cremoux, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Medecine Sciences : M/S|February 1, 2018
[Evolution, determinants and regulation of drug expenditures in France]Catherine Le Galès
Medecine Sciences : M/S|April 17, 2018
[Why are new drugs so expensive?]Catherine Le Galès
Dementia (London, England)|July 9, 2016
The family accompaniment of persons with dementia seen through the lens of the capability approachCatherine Le Galès, Martine Bungener
Bulletin Du Cancer|July 15, 2003
[Assessing fatigue in the cancer patient: complementary contribution of quantitative and qualitative tools]Sophia Rosman, Catherine Le Galès
Social Science & Medicine (1982)|January 17, 2016
Capability deprivation of people with Alzheimer's disease: An empirical analysis using a national surveyJuan Tellez, Jaya Krishnakumar, Martine Bungener, et al.
Therapie|December 6, 2003
Postmarketing evaluation of drugs. Actual efficacy, population exposed and impact on public healthCatherine Le Galès, Abdelkader el Hasnaoui, Jean-Marie Goehrs
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 29, 2005
Reliability and validity of the Functional Assessment of Cancer Therapy General (FACT-G) in French cancer patientsNathalie Costet, Valérie Lapierre, Ellen Benhamou, et al.
Bulletin Du Cancer|October 11, 2021
Challenges raised by the economic evaluation of CAR-T-cell therapies. The review by the French National Authority for HealthVéronique Raimond, Emmanuelle Kaltenbach, Christophe Adam, et al.
Diagnostic Cytopathology|October 3, 2002
Cost of screening for cancerous and precancerous lesions of the cervixEstelle Méréa, Catherine Le Galès, Beatrix Cochand-Priollet, et al.
BMJ (Clinical Research Ed.)|April 5, 2003
Cross sectional study of conventional cervical smear, monolayer cytology, and human papillomavirus DNA testing for cervical cancer screeningJoël Coste, Béatrix Cochand-Priollet, Patricia de Cremoux, et al.
Pageof 2